Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/ACH · Entity 6858 | Director · President & CEO | May 15, 2026 | May 19, 2026 |
| Fortrea Holdings Inc.FTRE · Entity 4623 | Director | June 10, 2026 | June 12, 2026 |
| THERMO FISHER SCIENTIFIC INC.TMO · Entity 2836 | Senior Vice President | March 05, 2015 | March 09, 2015 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCENDRA HEALTH INC/VA/
Report date May 15, 2026 · Filed May 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,072,785 |
Reported balance
After 2026-05-15 transaction · row 1
1 source rowRow 1 · 2026-05-15 · Tax withholding · Disposed 17,692 · Balance 1,072,785 F1: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.
Fortrea Holdings Inc.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,453 |
Reported balance
After 2026-06-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-10 · Exercise / conversion · Acquired 38,817 · Balance 52,453 F1: Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of Fortrea Holdings Inc. ("Fortrea") common stock ("Common Stock"). This transaction represents the settlement of RSUs into Common Stock on their scheduled vesting date. F2: This number reflects the aggregate amount of Common Stock held by the reporting person. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-10 · Exercise / conversion · Disposed 38,817 · Balance 0 F1: Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of Fortrea Holdings Inc. ("Fortrea") common stock ("Common Stock"). This transaction represents the settlement of RSUs into Common Stock on their scheduled vesting date. F3: Represents an RSU award that vested in its entirety on June 10, 2026. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 12,852 |
Reported balance
After 2026-06-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-10 · Grant · Acquired 12,852 · Balance 12,852 F4: Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of Fortrea Holdings Inc. ("Fortrea") common stock ("Common Stock"). F5: Represents a RSU award that vests in its entirety twelve months after June 10, 2026, subject to the Reporting Person's continued service as a director. F6: This number reflects the aggregate number of RSUs held by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of Fortrea Holdings Inc. ("Fortrea") common stock ("Common Stock"). This transaction represents the settlement of RSUs into Common Stock on their scheduled vesting date.
F2: This number reflects the aggregate amount of Common Stock held by the reporting person.
F3: Represents an RSU award that vested in its entirety on June 10, 2026.
F4: Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of Fortrea Holdings Inc. ("Fortrea") common stock ("Common Stock").
F5: Represents a RSU award that vests in its entirety twelve months after June 10, 2026, subject to the Reporting Person's continued service as a director.
F6: This number reflects the aggregate number of RSUs held by the reporting person.
THERMO FISHER SCIENTIFIC INC.
Report date March 05, 2015 · Filed March 09, 2015
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 80,641 |
Ending reported balance
After 2015-03-05 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2015-03-05 · Exercise / conversion · Acquired 7,250 · Balance 87,891 Row 2 · 2015-03-05 · Sale · Disposed 100 · Balance 87,791 Row 3 · 2015-03-05 · Sale · Disposed 7,150 · Balance 80,641 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.49 · Expires 2017-03-05 | Direct | 0 |
Reported balance
After 2015-03-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2015-03-05 · Exercise / conversion · Disposed 7,250 · Balance 0 F1: The option vested in four equal installments on March 5, 2012, 2013, 2014 and 2015. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vested in four equal installments on March 5, 2012, 2013, 2014 and 2015.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 03, 2021 Filed Nov 4, 2021 23:50 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 3,598 | $40.31 | $145,035.38 |
DisclosureSEC source: 0001062993-21-010283 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,316,828 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. F2 · price: Weighted average of the sale price range of $40.00 through $40.90 Read SEC document |
| August 11, 2021 Filed Aug 13, 2021 20:19 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 23,918 | $38.63 | $923,952.34 |
DisclosureSEC source: 0000075252-21-000139 · edgar.xml · nonDerivative · entry 2 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,320,426 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. F3 · price: Weighted average of the sale price range of $38.08 through $39.06. Read SEC document |
| August 11, 2021 Filed Aug 13, 2021 20:19 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 7,867 | $38.72 | $304,602.37 |
DisclosureSEC source: 0000075252-21-000139 · edgar.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,344,344 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. F2 · price: Weighted average of the sale price range of $38.10 through $39.09. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 20:32 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 31,978 | $38.16 | $1,220,280.48 |
DisclosureSEC source: 0000075252-21-000134 · edgar.xml · nonDerivative · entry 6 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,352,211 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. F8 · price: Weighted average of the sale price range of $37.60 through $38.51. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 20:32 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 28,276 | $38.11 | $1,077,626.64 |
DisclosureSEC source: 0000075252-21-000134 · edgar.xml · nonDerivative · entry 5 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,384,189 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. F7 · price: Weighted average of the sale price range of $37.60 through $38.52. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 20:32 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 5,348 | $38.81 | $207,577.27 |
DisclosureSEC source: 0000075252-21-000134 · edgar.xml · nonDerivative · entry 4 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,412,465 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. F5 · price: Weighted average of the sale price range of $38.80 through $38.85. F6 · balance_after: Balance includes employee stock purchase plan holdings not previously reflected in beneficial ownership total. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 20:32 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 40,579 | $38.42 | $1,559,004.60 |
DisclosureSEC source: 0000075252-21-000134 · edgar.xml · nonDerivative · entry 3 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,417,161 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. F4 · price: Weighted average of the sale price range of $37.80 through $38.80. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 20:32 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 3,840 | $38.83 | $149,091.84 |
DisclosureSEC source: 0000075252-21-000134 · edgar.xml · nonDerivative · entry 2 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,457,740 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. F3 · price: Weighted average of the sale price range of $38.80 through $38.86. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 20:32 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 42,243 | $38.44 | $1,623,736.43 |
DisclosureSEC source: 0000075252-21-000134 · edgar.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,461,580 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. F2 · price: Weighted average of the sale price range of $37.80 through $38.80. Read SEC document |
| May 11, 2021 Filed May 13, 2021 12:59 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 46,531 | $33.41 | $1,554,600.71 |
DisclosureSEC source: 0000075252-21-000102 · edgar.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,503,823 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 13:23 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 59,101 | $32.39 | $1,914,281.39 |
DisclosureSEC source: 0000075252-21-000061 · edgar.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,550,354 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:39 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 64,441 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-21-000048 · edgar.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,609,455 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 21:18 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 856,532 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-21-000024 · edgar.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,545,014 F1 · security: Restricted stock which vests on March 4, 2022. F2 · balance_after: Balance includes employee stock purchase plan holdings and/or shares acquired through dividend reinvestment transactions not previously reflected in beneficial ownership total. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:08 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 303,449 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-20-000066 · edgar.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 687,928 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 20:45 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 43,787 | $5.61 | $245,645.07 |
DisclosureSEC source: 0000075252-20-000031 · edgar.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,479 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| March 07, 2019 Filed Mar 9, 2019 01:52 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 428,266 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-19-000052 · edgar.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,266 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| March 05, 2015 Filed Mar 9, 2015 20:34 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,250 | $0.00 Strike: $49.49 | $0.00 |
DisclosureSEC source: 0001127602-15-010612 · form4.xml · derivative · entry 4 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,250 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in four equal installments on March 5, 2012, 2013, 2014 and 2015. Read SEC document |
| March 05, 2015 Filed Mar 9, 2015 20:34 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 7,150 | $131.06 | $937,079.00 |
DisclosureSEC source: 0001127602-15-010612 · form4.xml · nonDerivative · entry 3 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,641 Read SEC document |
| March 05, 2015 Filed Mar 9, 2015 20:34 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 100 | $131.05 | $13,105.00 |
DisclosureSEC source: 0001127602-15-010612 · form4.xml · nonDerivative · entry 2 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,791 Read SEC document |
| March 05, 2015 Filed Mar 9, 2015 20:34 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 7,250 | $49.49 | $358,802.50 |
DisclosureSEC source: 0001127602-15-010612 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2015 Filed Mar 4, 2015 20:02 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 6,169 | $131.35 | $810,298.15 |
DisclosureSEC source: 0001127602-15-009986 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,641 Read SEC document |
| February 26, 2015 Filed Mar 2, 2015 21:46 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,400 | $0.00 Strike: $124.28 | $0.00 |
DisclosureSEC source: 0001127602-15-009106 · form4.xml · derivative · entry 6 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,200 Underlying: Common Stock · 7,400 shares Expires 2021-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 26, 2015. Read SEC document |
| February 26, 2015 Filed Mar 2, 2015 21:46 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,900 | $0.00 Strike: $73.24 | $0.00 |
DisclosureSEC source: 0001127602-15-009106 · form4.xml · derivative · entry 5 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,800 Underlying: Common Stock · 10,900 shares Expires 2020-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 26, 2014. Read SEC document |
| February 26, 2015 Filed Mar 2, 2015 21:46 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 1,355 | $130.14 | $176,339.70 |
DisclosureSEC source: 0001127602-15-009106 · form4.xml · nonDerivative · entry 4 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,810 Read SEC document |
| February 26, 2015 Filed Mar 2, 2015 21:46 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 18,300 | $130.08 | $2,380,464.00 |
DisclosureSEC source: 0001127602-15-009106 · form4.xml · nonDerivative · entry 3 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,165 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.89 to $130.24, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 26, 2015 Filed Mar 2, 2015 21:46 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 10,900 | $73.24 | $798,316.00 |
DisclosureSEC source: 0001127602-15-009106 · form4.xml · nonDerivative · entry 2 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,465 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2015 Filed Mar 2, 2015 21:46 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 7,400 | $124.28 | $919,672.00 |
DisclosureSEC source: 0001127602-15-009106 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,565 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2015 Filed Feb 27, 2015 22:03 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 3,917 | $131.07 | $513,401.19 |
DisclosureSEC source: 0001127602-15-008823 · form4.xml · nonDerivative · entry 2 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,165 Read SEC document |
| February 25, 2015 Filed Feb 27, 2015 22:03 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantCommon Stock | 10,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-15-008823 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,082 F1 · shares: Shares represent a performance-based restricted stock unit award granted on February 26, 2014. The Company's Compensation Committee determined on February 25, 2015, that the performance criteria related to this award was satisfied. One-third of the shares vested on February 25, 2015, one-third of the shares vest on February 25, 2016, and the remaining one-third vest on February 25, 2017. Read SEC document |
| February 23, 2015 Filed Feb 25, 2015 23:26 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,900 | $0.00 Strike: $73.24 | $0.00 |
DisclosureSEC source: 0001127602-15-008407 · form4.xml · derivative · entry 6 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,700 Underlying: Common Stock · 10,900 shares Expires 2020-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 26, 2014. Read SEC document |
| February 23, 2015 Filed Feb 25, 2015 23:26 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 17,813 | $0.00 Strike: $54.97 | $0.00 |
DisclosureSEC source: 0001127602-15-008407 · form4.xml · derivative · entry 5 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,813 shares Expires 2018-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 23, 2012. Read SEC document |
| February 23, 2015 Filed Feb 25, 2015 23:26 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 1,907 | $130.98 | $249,778.86 |
DisclosureSEC source: 0001127602-15-008407 · form4.xml · nonDerivative · entry 4 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,594 Read SEC document |
| February 23, 2015 Filed Feb 25, 2015 23:26 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 28,713 | $130.93 | $3,759,393.09 |
DisclosureSEC source: 0001127602-15-008407 · form4.xml · nonDerivative · entry 3 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,501 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.88 to $131.01, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 23, 2015 Filed Feb 25, 2015 23:26 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 10,900 | $73.24 | $798,316.00 |
DisclosureSEC source: 0001127602-15-008407 · form4.xml · nonDerivative · entry 2 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2015 Filed Feb 25, 2015 23:26 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 17,813 | $54.97 | $979,180.61 |
DisclosureSEC source: 0001127602-15-008407 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2014 Filed Sep 4, 2014 20:53 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 53,437 | $0.00 Strike: $54.97 | $0.00 |
DisclosureSEC source: 0001127602-14-027217 · form4.xml · derivative · entry 4 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,813 Underlying: Common Stock · 53,437 shares Expires 2018-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on February 23, 2012, 2013 and 2014, and the next installment becomes exercisable on February 23, 2015. Read SEC document |
| September 02, 2014 Filed Sep 4, 2014 20:53 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 47,337 | $122.06 | $5,777,954.22 |
DisclosureSEC source: 0001127602-14-027217 · form4.xml · nonDerivative · entry 3 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,501 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2014. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.61 to $122.55, inclusive. Read SEC document |
| September 02, 2014 Filed Sep 4, 2014 20:53 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 20,644 | $121.28 | $2,503,704.32 |
DisclosureSEC source: 0001127602-14-027217 · form4.xml · nonDerivative · entry 2 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,838 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2014. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.64 to $121.60, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| September 02, 2014 Filed Sep 4, 2014 20:53 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 53,437 | $54.97 | $2,937,431.89 |
DisclosureSEC source: 0001127602-14-027217 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,482 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 26, 2014 Filed Aug 28, 2014 23:34 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 2,785 | $120.71 | $336,177.35 |
DisclosureSEC source: 0001127602-14-026760 · form4.xml · nonDerivative · entry 2 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,045 Read SEC document |
| March 24, 2014 Filed Mar 26, 2014 22:45 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 21,750 | $0.00 Strike: $49.49 | $0.00 |
DisclosureSEC source: 0001127602-14-012779 · form4.xml · derivative · entry 9 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,250 Underlying: Common Stock · 21,750 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on March 5, 2012, 2013 and 2014, and the next installment becomes exercisable on March 5, 2015. Read SEC document |
| March 24, 2014 Filed Mar 26, 2014 22:45 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 53,300 | $0.00 Strike: $49.49 | $0.00 |
DisclosureSEC source: 0001127602-14-012779 · form4.xml · derivative · entry 8 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53,300 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option vested in four equal annual installments on March 5, 2011, 2012, 2013 and 2014. Read SEC document |
| March 24, 2014 Filed Mar 26, 2014 22:45 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 200 | $123.51 | $24,702.00 |
DisclosureSEC source: 0001127602-14-012779 · form4.xml · nonDerivative · entry 7 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,030 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2014. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.50 to 123.52, inclusive. Read SEC document |
| March 24, 2014 Filed Mar 26, 2014 22:45 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 11,000 | $122.89 | $1,351,790.00 |
DisclosureSEC source: 0001127602-14-012779 · form4.xml · nonDerivative · entry 6 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,230 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2014. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.47 to 123.42, inclusive. Read SEC document |
| March 24, 2014 Filed Mar 26, 2014 22:45 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 8,662 | $121.78 | $1,054,858.36 |
DisclosureSEC source: 0001127602-14-012779 · form4.xml · nonDerivative · entry 5 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,230 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2014. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.35 to 122.31, inclusive. Read SEC document |
| March 24, 2014 Filed Mar 26, 2014 22:45 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 25,745 | $120.73 | $3,108,193.85 |
DisclosureSEC source: 0001127602-14-012779 · form4.xml · nonDerivative · entry 4 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,892 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2014. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.35 to 121.33, inclusive. Read SEC document |
| March 24, 2014 Filed Mar 26, 2014 22:45 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 34,437 | $119.80 | $4,125,552.60 |
DisclosureSEC source: 0001127602-14-012779 · form4.xml · nonDerivative · entry 3 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,637 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2014. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.40 to $120.32, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5) and (6) to this Form 4. Read SEC document |
| March 24, 2014 Filed Mar 26, 2014 22:45 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 21,750 | $49.49 | $1,076,407.50 |
DisclosureSEC source: 0001127602-14-012779 · form4.xml · nonDerivative · entry 2 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,074 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2014 Filed Mar 26, 2014 22:45 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 53,300 | $49.49 | $2,637,817.00 |
DisclosureSEC source: 0001127602-14-012779 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2014 Filed Mar 7, 2014 22:14 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 1,621 | $125.91 | $204,100.11 |
DisclosureSEC source: 0001127602-14-010735 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,024 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.